UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study

Neurology, 2015-08, Vol.85 (8), p.675-682

2015

Volltextzugriff (PDF)

Statin-related adverse events: A meta-analysis

Clinical therapeutics, 2006, Vol.28 (1), p.26-35

2006

Volltextzugriff (PDF)

Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease

Cholesterol, 2010, Vol.2010 (2010), p.28-38

2010

Volltextzugriff (PDF)

Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia

Leukemia & lymphoma, 2012-03, Vol.53 (3), p.435-440

2012

Volltextzugriff (PDF)

Outcomes of patients with hereditary transthyretin-mediated amyloidosis with early onset V30M versus all other mutations in APOLLO, a Phase 3 study of patisiran

Revue neurologique, 2019-04, Vol.175, p.S129-S129

2019

Volltextzugriff (PDF)

Antifactor Xa Levels in Four Patients with Burn Injuries Who Received Enoxaparin to Prevent Venous Thromboembolism

Pharmacotherapy, 2004-12, Vol.24 (12), p.1793-1799

2004

Volltextzugriff (PDF)

Emergency management of hemorrhagic complications in the era of glycoprotein IIb/IIIa receptor antagonists, clopidogrel, low molecular weight heparin, and third-generation fibrinolytic agents

Current cardiology reports, 2003-07, Vol.5 (4), p.310-317

2003

Volltextzugriff (PDF)

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?

Vascular health and risk management, 2006, Vol.2 (1), p.39-48

2006

Volltextzugriff (PDF)

CD40 ligand: a novel target in the fight against cardiovascular disease

The Annals of pharmacotherapy, 2004-09, Vol.38 (9), p.1500-1508

2004

Volltextzugriff (PDF)

Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists

Journal of managed care pharmacy, 2007-09, Vol.13 (7), p.598-606

2007

Volltextzugriff (PDF)

Antifactor Xa Levels in Four Patients with Burn Injuries Who Received Enoxaparin to Prevent Venous Thromboembolism

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004, Vol.24 (12), p.1793-1799

2004

Volltextzugriff (PDF)

Effect of sensory nerve conduction studies of median and ulnar nerve: Height and body mass index

National journal of physiology, pharmacy and pharmacology, 2021, Vol.11 (6), p.1-336

2021

Volltextzugriff (PDF)

Patisiran, an Investigational RNAi Therapeutic for Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy: Results from the Phase 3 APOLLO study (CT.001)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

A Comparative Study of Simple Auditory Reaction Time in Blind (Congenitally) and Sighted Subjects

Indian journal of psychological medicine, 2013-07, Vol.35 (3), p.273-277

2013

Volltextzugriff (PDF)

Handedness affecting sensory nerve conduction study of median and ulnar nerve

National journal of physiology, pharmacy and pharmacology, 2021, Vol.11 (10), p.1-1202

2021

Volltextzugriff (PDF)

Public Health Actions to Control Measles Among Afghan Evacuees During Operation Allies Welcome - United States, September-November 2021

MMWR. Morbidity and mortality weekly report, 2022-04, Vol.71 (17), p.592-596

2022

Volltextzugriff (PDF)

Mobilization with Plerixafor (Mozobil ®)Plus G-CSF Results in Superior Day 1 Collection of CD34+ Cells Compared to Placebo Plus G-CSF: Results From Two Randomized Placebo-Controlled Trials in Patients with Multiple Myeloma or Non-Hodgkin's Lymphoma

Blood, 2009-11, Vol.114 (22), p.3224-3224

2009

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

KollektionOxford journals

ThemaPeripheral Vascular Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(18)
Berichte
(1)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study

Statin-related adverse events: A meta-analysis

Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease

Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia

Outcomes of patients with hereditary transthyretin-mediated amyloidosis with early onset V30M versus all other mutations in APOLLO, a Phase 3 study of patisiran

Antifactor Xa Levels in Four Patients with Burn Injuries Who Received Enoxaparin to Prevent Venous Thromboembolism

Emergency management of hemorrhagic complications in the era of glycoprotein IIb/IIIa receptor antagonists, clopidogrel, low molecular weight heparin, and third-generation fibrinolytic agents

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?

CD40 ligand: a novel target in the fight against cardiovascular disease

Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists

Antifactor Xa Levels in Four Patients with Burn Injuries Who Received Enoxaparin to Prevent Venous Thromboembolism

Effect of sensory nerve conduction studies of median and ulnar nerve: Height and body mass index

Patisiran, an Investigational RNAi Therapeutic for Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy: Results from the Phase 3 APOLLO study (CT.001)

Evaluation of Quality of Life and Disability in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy Following Treatment with Patisiran, An Investigational RNAi Therapeutic: Results from the Phase 3 APOLLO Study (S31.003)

A Comparative Study of Simple Auditory Reaction Time in Blind (Congenitally) and Sighted Subjects

Handedness affecting sensory nerve conduction study of median and ulnar nerve

Public Health Actions to Control Measles Among Afghan Evacuees During Operation Allies Welcome - United States, September-November 2021

Mobilization with Plerixafor (Mozobil ®)Plus G-CSF Results in Superior Day 1 Collection of CD34+ Cells Compared to Placebo Plus G-CSF: Results From Two Randomized Placebo-Controlled Trials in Patients with Multiple Myeloma or Non-Hodgkin's Lymphoma

Aktive Filter

Suchergebnisse filtern